The comparison of the effect of dexmedetomidine-remifentanil versus propofol-remifentanil for monitored anesthesia care during hysteroscopy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000616

Enrollment

Registered

2012-12-27

Start date

2012-06-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Remifentanil will be infused continuously using a target-controlled infusion pump in both groups. The effect-site concentration will be initially set at 2 ng/ml before the start of the operatio

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: female patients, aged 18-70 yr with American Society of Anesthesiologists' classification I - II, and undergoing elective hysteroscopy under MAC

Exclusion criteria

Exclusion criteria: 1) possibility of anatomical abnormality causing difficulty in airway management 2) history of respiratory insufficiency or sleep apnea 3) Chronic use of analgesics 4) History of drug abuse 5) Allergy to study drugs 6) patient’s refusal of informed consent.

Design outcomes

Primary

Measure	Time frame
The incidence of respiratory depression during the operation	—

Secondary

Measure	Time frame
Intraoperative mean arterial pressure ;Intraoperative heart rate;Duration of PACU (postanesthesia care unit) stay;Postoperative mean arterial pressure;Postoperative heart rate;Satisfaction score of the anesthesia;The severity of intraoperative pain ;The severity of postoperative pain ;The severity of postoprative nausea;Total amount of remifentanil used during the operation	—

Countries

Korea, Republic of

Contacts

Public ContactSeongjoo Park

Seoul National University Bundang Hospital

struka@snubh.org+82-31-787-7512

Outcome results